Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ian Paterson

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
JACC. Advances|June 28, 2024
TITAN Trial: A Randomized Controlled Trial of a Cardiac Rehabilitation Care Model in Breast CancerAmy A Kirkham, John R Mackey, Richard B Thompson, et al.
Nature Communications|July 27, 2025
Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agentsSaymon Tejay, Maria Areli Lorenzana-Carrillo, Guocheng Huang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 19, 2021
Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: a secondary analysis of the MANTICORE trialAmy A Kirkham, Edith Pituskin, Richard B Thompson, et al.
ESC Heart Failure|September 27, 2021
Cardiac remodelling predicts outcome in patients with chronic heart failureLingyu Xu, Joseph Pagano, Kelvin Chow, et al.
Circulation|January 9, 2020
OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B)D Ian Paterson, George Wells, Fernanda Erthal, et al.
BMC Cancer|October 11, 2021
Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual careAmy A Kirkham, Karen King, Anil A Joy, et al.
Frontiers in Medicine|August 8, 2024
Rationale and design of the multi organ inflammation with serial testing study: a comprehensive assessment of functional and structural abnormalities in patients with recovered COVID-19D Ian Paterson, James A White, Christian Beaulieu, et al.
Journal of the American Heart Association|April 21, 2021
Effect of Active Cancer on the Cardiac Phenotype: A Cardiac Magnetic Resonance Imaging-Based Study of Myocardial Tissue Health and Deformation in Patients With Chemotherapy-Naïve CancerDina Labib, Alessandro Satriano, Steven Dykstra, et al.
European Heart Journal. Cardiovascular Imaging|January 18, 2024
Sex-based differences in the phenotypic expression and prognosis of idiopathic non-ischaemic cardiomyopathy: a cardiovascular magnetic resonance studyMaggie Mallabone, Dina Labib, Ahmed Abdelhaleem, et al.
Plos One|September 28, 2020
Screening for Fabry Disease in patients with unexplained left ventricular hypertrophyChandu Sadasivan, Josie T Y Chow, Bun Sheng, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
JACC. Advances|June 28, 2024
TITAN Trial: A Randomized Controlled Trial of a Cardiac Rehabilitation Care Model in Breast CancerAmy A Kirkham, John R Mackey, Richard B Thompson, et al.
Nature Communications|July 27, 2025
Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agentsSaymon Tejay, Maria Areli Lorenzana-Carrillo, Guocheng Huang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 19, 2021
Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: a secondary analysis of the MANTICORE trialAmy A Kirkham, Edith Pituskin, Richard B Thompson, et al.
ESC Heart Failure|September 27, 2021
Cardiac remodelling predicts outcome in patients with chronic heart failureLingyu Xu, Joseph Pagano, Kelvin Chow, et al.
Circulation|January 9, 2020
OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B)D Ian Paterson, George Wells, Fernanda Erthal, et al.
BMC Cancer|October 11, 2021
Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual careAmy A Kirkham, Karen King, Anil A Joy, et al.
Frontiers in Medicine|August 8, 2024
Rationale and design of the multi organ inflammation with serial testing study: a comprehensive assessment of functional and structural abnormalities in patients with recovered COVID-19D Ian Paterson, James A White, Christian Beaulieu, et al.
Journal of the American Heart Association|April 21, 2021
Effect of Active Cancer on the Cardiac Phenotype: A Cardiac Magnetic Resonance Imaging-Based Study of Myocardial Tissue Health and Deformation in Patients With Chemotherapy-Naïve CancerDina Labib, Alessandro Satriano, Steven Dykstra, et al.
European Heart Journal. Cardiovascular Imaging|January 18, 2024
Sex-based differences in the phenotypic expression and prognosis of idiopathic non-ischaemic cardiomyopathy: a cardiovascular magnetic resonance studyMaggie Mallabone, Dina Labib, Ahmed Abdelhaleem, et al.
Plos One|September 28, 2020
Screening for Fabry Disease in patients with unexplained left ventricular hypertrophyChandu Sadasivan, Josie T Y Chow, Bun Sheng, et al.
Pageof 8